{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:29:06Z","timestamp":1791415746257,"version":"4.3.3"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1097\/fbp.0000000000000025","type":"journal-article","created":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T11:18:10Z","timestamp":1392290290000},"page":"137-146","source":"Crossref","is-referenced-by-count":26,"title":["Analgesic efficacy of small-molecule angiotensin II type 2 receptor antagonists in a rat model of antiretroviral toxic polyneuropathy"],"prefix":"10.1097","volume":"25","author":[{"given":"Maree T.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria C.J.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Wyse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.C.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-5-20210202","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/483531a","article-title":"Raise standards for preclinical cancer research.","volume":"483","author":"Begley","year":"2012","journal-title":"Nature"},{"key":"R4-5-20210202","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1744-8069-5-48","article-title":"Increased chemokine signaling in a model of HIV1-associated peripheral neuropathy.","volume":"5","author":"Bhangoo","year":"2009","journal-title":"Mol Pain"},{"key":"R5-5-20210202","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0028-3908(89)90081-6","article-title":"Effect of 5-HT1A agonists on stress-induced deficit in open field locomotor activity of rats: evidence that this model identifies anxiolytic-like activity.","volume":"28","author":"Carli","year":"1989","journal-title":"Neuropharmacology"},{"key":"R7-5-20210202","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2217\/pmt.12.67","article-title":"Painful HIV-associated sensory neuropathy.","volume":"2","author":"Cherry","year":"2012","journal-title":"Pain Management"},{"key":"R9-5-20210202","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrd1825","article-title":"The ascent of mouse: advances in modeling human depression and anxiety.","volume":"4","author":"Cryan","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"R10-5-20210202","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1529-8027.2001.006001014.x","article-title":"Peripheral neuropathy and antiretroviral drugs.","volume":"6","author":"Dalakas","year":"2001","journal-title":"J Peripher Nerv Syst"},{"key":"R11-5-20210202","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00221-009-1724-6","article-title":"Ectopic discharge in Abeta afferents as a source of neuropathic pain.","volume":"196","author":"Devor","year":"2009","journal-title":"Exp Brain Res"},{"key":"R14-5-20210202","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.pain.2010.06.019","article-title":"The evidence for pharmacological treatment of neuropathic pain.","volume":"150","author":"Finnerup","year":"2010","journal-title":"Pain"},{"key":"R16-5-20210202","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0149-7634(01)00012-4","article-title":"Targeted gene mutation approaches to the anxiety-like behavior in mice.","volume":"25","author":"Holmes","year":"2001","journal-title":"Neurosci Biobehav Rev"},{"key":"R20-5-20210202","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1529-8027.2012.00373.x","article-title":"Pathogenesis of HIV-associated sensory neuropathy: evidence from in vivo and in vitro experimental models.","volume":"17","author":"Kamerman","year":"2012","journal-title":"J Peripher Nerv Syst"},{"key":"R21-5-20210202","doi-asserted-by":"crossref","first-page":"14711","DOI":"10.1021\/bi035596s","article-title":"Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase.","volume":"42","author":"Lee","year":"2003","journal-title":"Biochemistry"},{"key":"R27-5-20210202","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/978-3-540-79090-7_12","article-title":"Cytokine and chemokine regulation of sensory neuron function.","volume":"194","author":"Miller","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"R29-5-20210202","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0165-0270(98)00083-1","article-title":"Assessing mechanical allodynia in the rat paw with a new electronic algometer.","volume":"84","author":"Moller","year":"1998","journal-title":"J Neurosci Methods"},{"key":"R30-5-20210202","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/pme.12258","article-title":"Analgesic efficacy and mode of action of a selective small molecule angiotensin II type 2 receptor antagonist, in a rat model of prostate cancer-induced bone pain.","volume":"15","author":"Muralidharan","year":"2013","journal-title":"Pain Med"},{"key":"R31-5-20210202","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.4049\/jimmunol.166.4.2695","article-title":"CXC chemokine receptor 4 expression and function in human astroglioma cells.","volume":"166","author":"Oh","year":"2011","journal-title":"J Immunol"},{"key":"R33-5-20210202","doi-asserted-by":"crossref","first-page":"e14433","DOI":"10.1371\/journal.pone.0014433","article-title":"Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials.","volume":"5","author":"Phillips","year":"2010","journal-title":"PLoS One"},{"key":"R37-5-20210202","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1212\/01.wnl.0000314647.35825.9c","article-title":"Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy.","volume":"70","author":"Simpson","year":"2008","journal-title":"Neurology"},{"key":"R38-5-20210202","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1111\/pme.12157","article-title":"A small molecule angiotensin II type 2 receptor (AT2R) antagonist produces analgesia in a rat model of neuropathic pain by inhibition of p38 mitogen activated protein kinase (MAPK) and p44p42 MAPK activation in the dorsal root ganglia.","volume":"14","author":"Smith","year":"2013","journal-title":"Pain Med"},{"key":"R39-5-20210202","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/pme.12063","article-title":"Small molecule angiotensin II type 2 receptor (AT2R) antagonists as novel analgesics for neuropathic pain: comparative pharmacokinetics, radioligand binding and efficacy in rats.","volume":"14","author":"Smith","year":"2013","journal-title":"Pain Med"},{"key":"R42-5-20210202","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1006\/exnr.2000.7371","article-title":"Enlargement of the receptive field size to low intensity mechanical stimulation in the rat spinal nerve ligation model of neuropathy.","volume":"163","author":"Suzuki","year":"2000","journal-title":"Exp Neurol"},{"key":"R44-5-20210202","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1093\/brain\/awm195","article-title":"Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain.","volume":"130","author":"Wallace","year":"2007","journal-title":"Brain"},{"key":"R45-5-20210202","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.neulet.2008.10.005","article-title":"Anxiety-like behavior is attenuated by gabapentin, morphine and diazepam in a rodent model of HIV anti-retroviral-associated neuropathic pain.","volume":"448","author":"Wallace","year":"2008","journal-title":"Neurosci Lett"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:00:32Z","timestamp":1620954032000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008877-201404000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000025","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}